The following trials are currently enrolling.
All of our studies are now conducted with special screening and safety protocols to reduce the risk of COVID-19.
For more information, click on the link to ClinicalTrials.gov or call the number indicated.
NCT01760005
DIAN-TU: Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation
UAB Investigator: Dr. Roberson
Study Coordinator: Amber Watkins (205-934-0946)
NCT04363684
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
UAB Investigator: Dr. Roberson
Study Coordinator: Loren Ashley (205-975-2779)
NCT02854033
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
UAB Investigator: Dr. Geldmacher
Study Coordinator: Loren Ashley (205-975-2779)
NCT04004767
TRC-PAD Program: In-Clinic Trial-Ready Corhort (TRC-PAD)
UAB Investigator: Dr. Geldmacher
Study Coordinator: Amber Watkins (205-934-0946)
The following trials are active but no longer recruiting, or were recently completed.
NCT02365922
DIAN-TU: Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation
UAB Investigator: Dr. Roberson
NCT02985879
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
UAB Investigator: Dr. Geldmacher
NCT03088956
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
UAB Investigator: Dr. Roberson
NCT02615002
TRC-PAD Program: In-Clinic Trial-Ready Corhort (TRC-PAD)
UAB Investigator: Dr. Geldmacher
NCT02569398
An Efficacy and Safety Study of JNJ-54861911 in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia (EARLY)
UAB Investigator: Dr. Geldmacher
NCT02484547
221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease (EMERGE)
UAB Investigator: Dr. Geldmacher
NCT02420756
Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study (IDEAS)
UAB Investigator: Dr. Roberson
NCT02008357
A4: Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
UAB Investigator: Dr. Geldmacher
NCT02167594
A09: Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
UAB Investigator: Dr. Roberson
NCT01767311
A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
UAB Investigator: Dr. Geldmacher
NCT01955161
STARSHINE: Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
UAB Investigator: Dr. Geldmacher
NCT02494024
A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects with Progressive Supranuclear Palsy
UAB Investigator: Dr. Roberson
NCT02460094
A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of Intravenously Administered BMS-986168 in Patients With Progressive Supranuclear Palsy
UAB Investigator: Dr. Geldmacher
NCT02133846
TPI-287-4RT: Safety Study of TPI-287 to Treat CBS and PSP
UAB Investigator: Dr. Roberson
NCT02534038
Safety, Tolerability and Efficacy of AVP-786 for the Treatment of Disinhibition
UAB Investigator: Dr. Geldmacher